BACKGROUND: Experimental data on tissue-specific effects and antigenotoxic potential facilitate more targeted practical applications of antigenotoxicants. AIM: This work aimed to assess the tissue-specific antigenotoxic activity of the natural flavonoids apigenin, naringenin, and hesperetin against the DNA-damaging effects of temozolomide and the cytogenetic effects of genotoxicants with various mechanisms of action. METHODS: The genotoxicants (temozolomide 50 mg/kg, cyclophosphamide 20 mg/kg, methyl methanesulfonate 80 mg/kg, and dioxydin 250 mg/kg) were administered intraperitoneally to mice. Before genotoxicant injections, three oral doses of apigenin (5, 25, and 50 mg/kg) and naringenin and hesperetin (25, 50, and 100 mg/kg) were given. In a separate experiment, apigenin was administered one hour after temozolomide injection. The study used a comet assay in bone marrow, liver, kidney, brain, and rectum cells, as well as chromosome aberration analysis in bone marrow cells. RESULTS: Apigenin decreased temozolomide-induced DNA damage in the bone marrow (52%–66%), liver (31%–65%), kidneys (50%), and rectum (100%), but not in the brain. All apigenin doses reduced kidney levels of atypical DNA comets. Naringenin demonstrated antigenotoxic activity by reducing DNA damage in the bone marrow (48%–62%), brain (26%–44%), and rectum (49%–54%), but not in the liver or kidneys. Hesperetin showed antigenotoxic effects in the bone marrow (23%), kidneys (29%–33%), brain (23%–42%), and rectum (32%–47%). In a cytogenetic assay, apigenin, naringenin, and hesperetin dose-dependently reduced the effects of temozolomide by 49%–73%, 49%–75%, and 39%–55%, respectively. In the post-treatment mode, apigenin 5–50 mg/kg reduced the effects of temozolomide by 47%–51%. Apigenin 5 mg/kg and 25 mg/kg markedly reduced the cytogenetic effects of dioxydin, while apigenin 25 mg/kg decreased those of cyclophosphamide and methyl methanesulfonate. Naringenin 50 mg/kg and 100 mg/kg reduced the effect of cyclophosphamide (43%–71%), but not dioxydin. CONCLUSION: Apigenin, naringenin, and hesperetin show tissue-specific antigenotoxic activity against the effects of temozolomide. Apigenin and naringenin reduce the cytogenetic effects of genotoxicants with various mechanisms of damaging action. The findings highlight the potential of the investigated flavonoids as genome-protecting agents with a possible targeted action.